FDA 483 - Linde Inc - March 26, 2026

An FDA inspection of Linde Inc, a medical gas manufacturer and distributor in Stockertown, PA, identified a significant quality control deficiency. The firm failed to establish a written testing program or conduct stability studies for its USP grade gases. This lapse resulted in the manufacturing and distribution of numerous product lots without proper stability assessment.